# Real World Data on Gi(l)Otrif® Dose Adjustment

> **NCT02751879** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 228 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02751879
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-24
- **Primary completion:** 2017-09-30
- **Final completion:** 2017-09-30
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2019-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02751879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02751879, "Real World Data on Gi(l)Otrif® Dose Adjustment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02751879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*